DE68915899D1 - Hemmung von HIV mittels Transformationswachstumsfaktor Beta. - Google Patents

Hemmung von HIV mittels Transformationswachstumsfaktor Beta.

Info

Publication number
DE68915899D1
DE68915899D1 DE68915899T DE68915899T DE68915899D1 DE 68915899 D1 DE68915899 D1 DE 68915899D1 DE 68915899 T DE68915899 T DE 68915899T DE 68915899 T DE68915899 T DE 68915899T DE 68915899 D1 DE68915899 D1 DE 68915899D1
Authority
DE
Germany
Prior art keywords
beta
tgf
hiv
inhibition
growth factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68915899T
Other languages
English (en)
Other versions
DE68915899T2 (de
Inventor
Vera Brankovan
Mario Lioubin
Anthony Purchio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of DE68915899D1 publication Critical patent/DE68915899D1/de
Application granted granted Critical
Publication of DE68915899T2 publication Critical patent/DE68915899T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE68915899T 1988-08-25 1989-08-25 Hemmung von HIV mittels Transformationswachstumsfaktor Beta. Expired - Fee Related DE68915899T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/236,698 US5236905A (en) 1988-08-25 1988-08-25 In vitro method of inhibition of HIV using transforming growth factor-.beta.

Publications (2)

Publication Number Publication Date
DE68915899D1 true DE68915899D1 (de) 1994-07-14
DE68915899T2 DE68915899T2 (de) 1994-10-13

Family

ID=22890582

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68915899T Expired - Fee Related DE68915899T2 (de) 1988-08-25 1989-08-25 Hemmung von HIV mittels Transformationswachstumsfaktor Beta.

Country Status (7)

Country Link
US (1) US5236905A (de)
EP (1) EP0356935B1 (de)
JP (1) JPH02160723A (de)
KR (1) KR900002798A (de)
AT (1) ATE106742T1 (de)
DE (1) DE68915899T2 (de)
IL (1) IL91389A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262319A (en) * 1985-04-19 1993-11-16 Oncogene Science, Inc. Method for obtaining bone marrow free of tumor cells using transforming growth factor β3
WO1991008291A2 (en) * 1989-11-22 1991-06-13 Genentech, Inc. Latency associated peptide and uses therefor
US5824297A (en) * 1990-06-25 1998-10-20 Oncogene Science, Inc. Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
US5780436A (en) * 1995-05-01 1998-07-14 The Regents Of The University Of California Peptide compositions with growth factor-like activity
US5661127A (en) * 1995-05-01 1997-08-26 The Regents Of The University Of California Peptide compositions with growth factor-like activity
US6638912B2 (en) 1995-05-01 2003-10-28 The Regents Of The University Of California Peptide compositions mimicking TGF-β activity
US6399078B1 (en) 1998-06-01 2002-06-04 University Of Maryland Biotechnology Institute Chemokine—glycosaminoglycan complexes and their use in treating or preventing receptor mediated diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
EP0268561A3 (de) * 1986-11-17 1988-10-26 Sandoz Ag Herstellung und Verwendung eines T-Zellen-Suppressorfaktors

Also Published As

Publication number Publication date
IL91389A (en) 1994-06-24
EP0356935A3 (de) 1991-04-03
IL91389A0 (en) 1990-04-29
EP0356935B1 (de) 1994-06-08
US5236905A (en) 1993-08-17
JPH02160723A (ja) 1990-06-20
EP0356935A2 (de) 1990-03-07
ATE106742T1 (de) 1994-06-15
DE68915899T2 (de) 1994-10-13
KR900002798A (ko) 1990-03-23

Similar Documents

Publication Publication Date Title
KR880701736A (ko) Il-6의 제조방법 및 용도
ATE77960T1 (de) Verwendung von interleukin-1 zur induzierung der bildung von multipotenten haemopoietischen zellpopulationen.
ATE191850T1 (de) Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung
DE68915317D1 (de) Carbohydratlactam-Derivate und ihre Verwendung in kosmetischen Verbindungen.
SE8804570D0 (sv) New ciclosporin crystal form process for its produktion pharmaceutical compositions containing it and its use
PT80300A (de) Herstellung von polypeptiden mit human-gammainterferonaktivitat
DE3776367D1 (de) Sterilisationsverfahren.
ATE148165T1 (de) Stabilisierung von hochgereinigten proteinen
DE68915899D1 (de) Hemmung von HIV mittels Transformationswachstumsfaktor Beta.
ATE107168T1 (de) Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression.
ATE43244T1 (de) Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung.
ES2047674T3 (es) Composicion cosmetica.
DE3875670D1 (de) 2-pyrimidinyl-1-piperazin-derivate zur behandlung von alkoholismus.
DE69131253T2 (de) Zur behandlung von tumoren und hiv-infektionen nützliches pflanzliches protein
ATE127842T1 (de) Megakaryocytopoietin, seine herstellung und benutzung.
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
DE3585416D1 (de) Verfahren zur herstellung eines biologischen stoffes.
ATE113828T1 (de) Kosmetische zusammensetzung.
DE59105850D1 (de) Mikrobiologisches Verfahren zur Herstellung von hydroxylierten Heterocyclen.
ATE53494T1 (de) Pharmazeutische zusammensetzungen zur behandlung des charcot-syndroms.
ATE48531T1 (de) Verfahren zum sterilisieren von rekombinantem mikroorganismus.
SU1387399A1 (ru) Питательная среда для культивирования лептоспир

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee